Integragen (ALINT) - Total Liabilities

Latest as of June 2025: €3.26 Million EUR ≈ $3.82 Million USD

Based on the latest financial reports, Integragen (ALINT) has total liabilities worth €3.26 Million EUR (≈ $3.82 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Integragen (ALINT) defensive interval to measure how many days the company can operate on defensive assets alone.

Integragen - Total Liabilities Trend (2008–2024)

This chart illustrates how Integragen's total liabilities have evolved over time, based on quarterly financial data. Check ALINT financial resilience to evaluate the company's liquid asset resilience ratio.

Integragen Competitors by Total Liabilities

The table below lists competitors of Integragen ranked by their total liabilities.

Company	Country	Total Liabilities
Mitra Komunikasi Nusantara Tbk PT JK:MKNT	Indonesia	Rp835.11 Billion
Desarrolladora Homex S.A.B. de C.V MX:HOMEX	Mexico	MX$1.00 Billion
LIFT GLOBAL VENT. LS-01 F:7XO	Germany	€214.30K
GO.D.M Investments Ltd TA:GODM	Israel	ILA165.00K
Windar Photonics Plc LSE:WPHO	UK	GBX2.79 Million
Rivalry Corp V:RVLY	Canada	CA$25.62 Million
Montfort Capital Corp V:MONT	Canada	CA$258.24 Million
Subsea 7 SA LSE:0OGK	UK	Nkr2.37 Billion

Liability Composition Analysis (2008–2024)

This chart breaks down Integragen's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Integragen (ALINT) total assets.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.19	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	9.66	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.91	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Integragen's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Integragen (2008–2024)

The table below shows the annual total liabilities of Integragen from 2008 to 2024.

Year	Total Liabilities	Change
2024-12-31	€3.76 Million ≈ $4.39 Million	-37.24%
2023-12-31	€5.99 Million ≈ $7.00 Million	-12.21%
2022-12-31	€6.82 Million ≈ $7.98 Million	-8.03%
2021-12-31	€7.42 Million ≈ $8.67 Million	+11.55%
2020-12-31	€6.65 Million ≈ $7.77 Million	+56.88%
2019-12-31	€4.24 Million ≈ $4.96 Million	-26.77%
2018-12-31	€5.79 Million ≈ $6.77 Million	+22.68%
2017-12-31	€4.72 Million ≈ $5.52 Million	-25.18%
2016-12-31	€6.31 Million ≈ $7.37 Million	+10.91%
2015-12-31	€5.69 Million ≈ $6.65 Million	+5.16%
2014-12-31	€5.41 Million ≈ $6.32 Million	+6.20%
2013-12-31	€5.09 Million ≈ $5.95 Million	+10.30%
2012-12-31	€4.62 Million ≈ $5.40 Million	+19.14%
2011-12-31	€3.87 Million ≈ $4.53 Million	+27.16%
2010-12-31	€3.05 Million ≈ $3.56 Million	+4.81%
2009-12-31	€2.91 Million ≈ $3.40 Million	+38.75%
2008-12-31	€2.10 Million ≈ $2.45 Million	--

About Integragen

PA:ALINT France Biotechnology

Market Cap

$319.78K

€273.52K EUR

Market Cap Rank

#31211 Global

#587 in France

Share Price

€0.04

Change (1 day)

-32.35%

52-Week Range

€0.04 - €0.36

All Time High

€7.02